|
JP2020200292A
|
|
Composition for prevention or treatment of alcoholic liver disease
|
|
JP2019189563A
|
|
Antiviral agent and antiviral composition
|
|
JP2019137644A
|
|
Antiviral agent and antiviral composition
|
|
JP2016119875A
|
|
Cell activator
|
|
JP2015057982A
|
|
Separation method of rhamnan sulfate assimilating bacteria
|
|
JP2011012036A
|
|
Method for producing cellulose decomposed product from seaweed residue
|
|
JP2008274085A
|
|
Method for producing rhamnan sulfate
|
|
JP2008127357A
|
|
External agent composition for skin
|
|
JP2008127358A
|
|
External agent composition for nail
|
|
JP2009057285A
|
|
Angiogenesis inhibitor and use thereof
|
|
JP2009057283A
|
|
Angiopathy ameliorating agent comprising sulfated polysaccharide derived from green alga, and method for producing the same
|
|
JP2003155283A
|
|
Kojic acid ester and method for synthesizing the same
|
|
JP2002065290A
|
|
Method for manufacturing sugar ester
|
|
JP2002065289A
|
|
Method of enzymatic transesterification reaction
|
|
JP2001169798A
|
|
Method for producing both enantiomers of optically active azulene trifluoroethanol derivative by use of lipase
|
|
JP2000300288A
|
|
Production of both enantiomers of optically active 4- alkanol compound
|
|
JPH08283180A
|
|
Production of charge transfer compound useful as electrophotographic photoreceptor
|
|
JPS62198636A
|
|
Novel azulene derivative and production thereof
|
|
JPS62129239A
|
|
Production of guaiazuleneindenonealdehyde
|
